Phase II Study of 2.5 gm of nicotinamide, given daily in 3 divided doses, to measure effect
on maternal blood pressure in women with early onset preeclampsia.
Phase:
Phase 2
Details
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborator:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)